Amanote Research

Amanote Research

    RegisterSign In

How Can Biosimilars Change the Trajectory of Breast Cancer Therapy?

Expert Review of Anticancer Therapy - United Kingdom
doi 10.1080/14737140.2020.1757438
Full Text
Open PDF
Abstract

Available in full text

Categories
OncologyPharmacology
Date

April 16, 2020

Authors
Dario TrapaniGiuseppe Curigliano
Publisher

Informa UK Limited


Related search

Biosimilars: How Can Payers Get Long-Term Savings?

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2016English

How Can Nanotechnology Help the Fight Against Breast Cancer?

Nanoscale
Materials ScienceNanotechnologyNanoscience
2018English

How to Improve Endocrine Therapy of Breast Cancer

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1990English

Can Endocrine Therapy Reduce the Risk of Breast Cancer in South African Women?

Wits Journal of Clinical Medicine
2020English

How Tattoos Can Complement Breast Reconstruction

AMA journal of ethics
Health PolicyEthicsHealthIssuesLegal Aspects
2018English

How Can We Prevent Cancer?

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2001English

Can We Prevent Breast Cancer?*

British Journal of Cancer
Cancer ResearchOncology
1991English

Antiangiogenic Therapy of Breast Cancer

2008English

Endocrine Therapy of Breast Cancer

2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy